FDA clears Insulet’s Omnipod Dash insulin management system

Insulet (NSDQ:PODD) said today that the FDA granted 510(k) clearance to its Omnipod Dash insulin management system.

The system wirelessly connects the company’s Personal Diabetes Manager with its tubeless, waterproof insulin pump. The PDM calculates how much insulin should be administered using blood glucose readings from the Contour Next One blood glucose meter. Altogether, the system connects via Bluetooth to the Omnipod Display and Omnipod View apps, which provide users and caregivers with access to their insulin therapy data.

Get the full story at our sister site, Drug Delivery Business News.

The post FDA clears Insulet’s Omnipod Dash insulin management system appeared first on MassDevice.

from MassDevice https://ift.tt/2LVPAyI